Pharmacotherapy for stimulant-related disorders
Colin N Haile1, Thomas R Kosten
1Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, TX, USA.
Current Psychiatry Reports
|October 22, 2013
Summary
No approved medications exist for stimulant-related disorders (SRD). Research into neural mechanisms and clinical trials show promise for new pharmacotherapies that may reverse deficits in individuals with SRD.
Area of Science:
- Neuroscience
- Pharmacology
- Public Health
Background:
- Stimulant-related disorders (SRD) represent a significant public health challenge.
- Current treatment options, primarily behavioral interventions, offer limited and variable benefits.
- There are no FDA-approved pharmacotherapies for SRD, highlighting an unmet medical need.
Purpose of the Study:
- To explore novel pharmacotherapeutic strategies for stimulant-related disorders.
- To investigate the potential of medications that can reverse neural deficits associated with stimulant use.
- To advance the development of effective treatments for SRD.
Main Methods:
- Review of research on neural mechanisms underlying stimulant action.
- Analysis of results from controlled clinical trials of potential pharmacotherapies.
- Evaluation of medications demonstrating promise in reversing neurobiological deficits.
Main Results:
- Understanding stimulant neurobiology has identified several promising pharmacotherapeutic candidates.
- Some candidate medications have shown positive outcomes in clinical trials.
- Evidence suggests certain treatments can reverse neural deficits in individuals with SRD.
Conclusions:
- Continued research and clinical trials are crucial for developing effective pharmacotherapies for SRD.
- Emerging treatments targeting neural deficits offer hope for improved patient outcomes.
- The development of novel pharmacotherapies for SRD is an active and promising area of research.
Related Concept Videos
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
1.5K
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
1.5K
01:29Stimulants
1.4K
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
1.4K
01:28Drug Therapy
450
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
450
01:23Drugs Acting on Autonomic Ganglia: Stimulants
2.2K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
2.2K
01:30Attention-Deficit/Hyperactivity Disorder
1.4K
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.4K
01:22CNS Stimulants: Psychedelic Agents
1.1K
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
1.1K